Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
Clinical trial NCT05035147 · RECRUITING
Trial details
- NCT number
- NCT05035147
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2026-04-01
- Enrollment
- 934
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.